April 13, 2022
Details of the Study
- To estimate the national economic cost of MS, researchers reviewed health claims data from Medicare and private insurer sources, and mortality data. They also conducted a survey of 946 people living with MS. The investigators compared costs between people with MS and matched people without MS.
- The team found that of the overall annual cost to the U.S. economy of $85.4 billion, $63.3 billion was in direct medical costs such as prescription drugs. Nearly $22.1 billion was in indirect or non-medical costs, including productivity loss, caregiver costs, and lost earnings.
- On an individual level, medical costs, especially DMTs, were the biggest cost of living with MS. The medical costs associated with living with MS are $65,612 more each year than medical costs for individuals who do not have MS. The annual costs to individuals on an MS disease-modifying therapy ranged from $57,202 to $92,719, depending on their age and gender.
Key Points
The National MS Society commissioned this study to better understand the financial burden of MS on people with MS, their families and the U.S. economy. While we have long understood that MS is an expensive disease, having data can help identify the most significant factors and direct our advocacy efforts to propel policy changes.The National MS Society is committed to ensuring people with MS have access to personalized, affordable, high-quality healthcare. The medical costs associated with living with MS are $65,612 more each year than for individuals who do not have MS, with the biggest medical cost being disease-modifying therapies. The Society is currently advocating for policies to reduce high prescription drug costs and helping people with MS afford high-quality health insurance, learn more here. Watch the Society’s Vice President of Advocacy, Steffany Stern’s testimony before the Senate Finance Committee and learn more about how to be an MS Activist. People with MS are protected from discrimination under the Americans with Disabilities Act (ADA). If you are experiencing financial or employment challenges related to MS, the National MS Society can help connect you to the information, resources and support you need.
- Connect with an MS Navigator by emailing [email protected] or calling 800-344-4867
- Get the Financial and Insurance Information you need
- Learn when and how to appeal an insurance decision
- Guide to prescription financial assistance
- Learn more about your employment rights and how to request accommodations
“The Economic Burden of Multiple Sclerosis in the U.S.: Estimate of Direct and Indirect Costs,” by Bruce Bebo, Inna Cintina, Nicholas LaRocca, Leslie Ritter, Bari Talente, Daniel Hartung, Surachat Ngorsuraches, Mitchell Wallin, and Grace Yang, was published online on April 13, 2022 in Neurology®, the medical journal of the American Academy of Neurology.
About Multiple Sclerosis
Multiple sclerosis is an unpredictable disease of the central nervous system. Currently there is no cure. Symptoms vary from person to person and may include disabling fatigue, mobility challenges, cognitive changes, and vision issues. An estimated 1 million people live with MS in the United States. Early diagnosis and treatment are critical to minimize disability. Significant progress is being made to achieve a world free of MS.
——————————–
Click to Subscribe for the MS Beacon eNewsletter and MS educational events